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Rationale: Panax quinquefolius (American Ginseng) is known for its therapeutic potential
against various neurological disorders, but its plausible mechanism of action still remains
undeciphered. GABA (Gamma Amino Butyric Acid) plays an important role in sleep wake
cycle homeostasis. Thus, there exists rationale in exploring the GABA-ergic potential of
Panax quinquefolius as neuroprotective strategy in sleep deprivation induced secondary
neurological problems.
Objective: The present study was designed to explore the possible GABA-ergic
mechanism in the neuro-protective effect of Panax quinquefolius against 72-h sleep
deprivation induced anxiety like behavior, oxidative stress, mitochondrial dysfunction,
HPA-axis activation and neuroinflammation.
Materials and Methods: Male laca mice were sleep deprived for 72-h by using Grid
suspended over water method. Panax quinquefolius (American Ginseng 50, 100, and
200 mg/kg) was administered alone and in combination with GABA modulators (GABA
Cl− channel inhibitor, GABA-benzodiazepine receptor inhibitor and GABAA agonist) for 8
days, starting 5 days prior to 72-h sleep deprivation period. Various behavioral (locomotor
activity, mirror chamber test), biochemical (lipid peroxidation, reduced glutathione,
catalase, nitrite levels), mitochondrial complexes, neuroinflammation marker (Tumor
Necrosis Factor, TNF-alpha), serum corticosterone, and histopathological sections of
brains were assessed.
Results: Seventy two hours sleep deprivation significantly impaired locomotor activity,
caused anxiety-like behavior, conditions of oxidative stress, alterations in mitochondrial
enzyme complex activities, raised serum corticosterone levels, brain TNFα levels and led
to neuroinflammation like signs in discrete brain areas as compared to naive group. Panax
quinquefolius (100 and 200mg/kg) treatment restored the behavioral, biochemical,
mitochondrial, molecular and histopathological alterations. Pre-treatment of GABA
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Cl− channel inhibitor as well as GABA-benzodiazepine receptor inhibitor, significantly
reversed the protective effect of P. quinquefolius (100mg/kg) in 72-h sleep deprived
animals (P < 0.05). However, pretreatment with GABAA agonist, potentiated Panax
quinquefolius’s protective effect which was significant as compared to their effect per
se (p < 0.05).
Conclusion: GABA-ergic mechanism could be involved in the neuroprotective effect of
P.quinquefolius against sleep deprivation induced anxiety-like behavior, oxidative stress,
mitochondrial dysfunction, HPA axis activation and neuroinflammation.
Keywords: anxiety, GABA, neuroinflammation, oxidative stress, Panax quinquefolius, sleep deprivation
INTRODUCTION
GABA (Gamma-amino-butyric-acid) is the cardinal inhibitory
neurotransmitter of the central nervous system (CNS) (Parades
and Agmo, 1992). It exerts its effects via three types of GABA
receptors viz ionotropic GABAAand GABAc (both coupled to
Cl− ionophore), and metabotropic GABAB receptors (which
are coupled to Ca2+ and K+ ion channels and function
via the involvement of a second messenger) (Barnard et al.,
1998; Bowery, 2006). The GABAA receptors are predominantly
expressed in the central nervous system while GABAC receptors
are primarily expressed in retina and optical layers of the superior
colliculi (Bloom and Iversen, 1971; McCabe andWamsley, 1986).
The GABAA receptor mediated Cl
− channel conductance is
responsible for the GABA-ergic inhibitory neurotransmission in
the CNS (Turner and Whittle, 1983).
GABA is also an important mediator of the sleep/wake
flip-flop cycle and plays pivotal role in maintenance of
sleep homeostasis. The sleep promoting VLPO (Ventero-lateral
preoptic nuclei) neurons of the anterior hypothalamus are
responsible for quietening the ascending monoaminergic arousal
system mediate their response via the release of two inhibitory
neurotransmitters GABA and galanin. Thus, GABAergic neurons
in the VLPO and adjacent BF (basal forebrain) play a critical role
in the induction and maintenance of sleep (Gallopin et al., 2000;
Manns et al., 2003; Jones, 2005).
Sleep deprivation [SD] has been reported to alter the content
of the GABA, suggesting that the GABA-ergic mechanism
play a critical role in sleep deprivation-induced behavioral
alterations and oxidative stress (Modirrousta et al., 2007).
The secondary detrimental manifestations associated with sleep
deprivation include anxiety like behavior, cognitive deficits,
oxidative stress (via accumulation of reactive oxygen species
(ROS), mitochondrial dysfunction, neuroinflammation etc. that
have all been individually responsible for affecting the GABA-
ergic transmission. Not only this, the various allosteric binding
sites of GABAA receptor have also served as potential therapeutic
targets for the management of SD induces anxiety like
problems (Modirrousta et al., 2007; Tadavarty et al., 2011). In
Abbreviations: BF, Basal forebrain; CRP, C-Reactive Protein; DNA,
deoxyribonucleic acid; GABA, gamma amino butyric acid; NO, nitric oxide;
GSH, reduced glutathione; H2O2, hydrogen peroxide; MDA, malondialdehyde;
SD, Sleep Deprivation, TNF, tumor necrosis factor; VLPO, Venterolateral preoptic.
addition to the mitochondrial electron transport chain, oxidative
dysregulation and accretion of ROS as a consequence of SD
may also be attributed to extramitochondrial sources such as
nicotinamide adenosine dinucleotide phosphate oxidases (NOX)
(Nair et al., 2011). The NOX are membrane bound enzyme
complexes that transfer electrons across biological membranes
to produce highly reactive superoxide ion and serve potent
inducers of oxidative dysregulation. Within the family of seven
different NOX isotypes, NOX2 is a prototype NADPH oxidase
that plays cardinal role in ROS generation in the CNS and thus
leads to neuronal degeneration via activation of oxidative stress
cascades contributing to extensive behavioral and pathological
conditions in several neuropsychiatric and neurodegenerative
diseases like anxiety, psychosis, schizophrenia, Alzheimer’s,
Parkinson’s disease etc. (Bedard and Krause, 2007; Behrens et al.,
2007; Schiavone et al., 2009, 2012; Sorce and Krause, 2009).
The link between increased corticosterone levels and GABA
mediated inhibitory potentials has also been explored and it
has been inferred that increased levels of corticosterone due to
stress slowly but persistently leads to inhibition of the GABA-
ergic tone (Verkuyl et al., 2005). Furthermore, elevated levels
of tumor necrosis factor (TNF-α) have also been reported
to deplete inhibitory synaptic strength. In response to TNF-
α binding to the neuronal TNFR1, there has been accounted
not only a down-regulation of GABA-ergic signaling but a
decline in the cell-surface levels of GABAA receptors as well
(Pribiag and Stellwagen, 2013). With the above background
it is speculated that development of secondary neurological
disorders as a consequence of SD can be attributed to a complex
interplay between oxidative stress, mitochondrial dysfunction,
neuroinflammatory responses and HPA-axis activation, all
accusing detrimental effects to the GABA-ergic inhibitory
signaling. Therefore, GABA-ergic signaling purports to be a
crucial link between sleep homeostasis, SD and development of
secondary neurological comorbidities associated with SD.
Panax quinquefolius (American ginseng) has served as a
valuable ingredient of the traditional medicine and this may
be attributed due to its array of beneficial effects produced on
the CNS (Radad et al., 2011). The CNS disorders benefitted
with P. quinquefolius treatment are found to be not only
confined to the traditional target diseases such as stress, anxiety
and ischemia but also expanded into progressive neurological
and psychiatric disorders including Alzheimer’s disease (AD),
Parkinson’s disease (PD), Huntington’s Disease and attention
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deficit hyperactivity disorder (ADHD) (Kim et al., 2013).
The neuroprotective aspects of Panax quinquefolius may be
accredited to its pharmacologically active constituents named
ginsenosides (mainly Rb1 and Rg1) which possess antioxidant,
anti-neuroinflammatory properties as well as possess potential
of modulating neurotransmitters release, synaptic plasticity
and neurogenesis (Nakaya et al., 2004; Park et al., 2009;
Radad et al., 2011). P. quinquefolius has also demonstrated
to possess GABA modulating effects; literature has reported
that ginsenosides regulate GABA-ergic neurotransmission via
modulating the ligand binding capacities at the GABAA
receptor or by directly increasing the Cl− channel activity by
interacting with γ2 subunit (Kim et al., 2001; Choi S. E. et al.,
2003; Lee et al., 2013). But till date the full potential of P.
quinquefolius remains untapped in leiu of its protective effects
and plausible mechanisms in SD induced secondary neurological
comorbidities. Therefore, with the above mentioned backdrop,
the present study had been designed with aim to investige
the possible interaction of P. quinquefolius with GABA-ergic
modulators in SD induced anxiety like behavior, conditions of
oxidative stress, mitochondrial dysfunction, HPA-axis activation
and neuroinflammation in mice.
MATERIALS AND METHODS
Animals
Male laca mice (22–30 g) bred in Central Animal House
(CAH) facility of the Punjab University, Chandigarh, India
were used. The animals were housed under standard laboratory
conditions and maintained under natural light-dark cycles. The
animals were acclimatized to laboratory conditions before actual
start of the experiment. All the experiments were carried out
between 09:00 and 17:00 h. The experimental protocol was
approved by Institutional Animal Ethics Committee (IAEC) of
Panjab University [Protocol no. IEAC/PU/282/UIPS-11, dated
5/02/2013] and carried out in accordance with the guidelines
of Committee for the Purpose of Control and Supervision of
Experimentation on Animals (CPCSEA), Government of India
and Indian National Science Academy Guidelines for the use and
care of experimental animals.
Sleep Deprivation
Animals were sleep-deprived for a total duration of 72-h by
using modified grid suspended over water method developed by
Shinomiya et al. (2003). Briefly, animals in a group of six to eight
were sleep deprived by placing on a grid floor (29 × 15 × 7 cm)
inside polyacrylic cages (38× 23× 10 cm), filled with water upto
1 cm below the grid surface for 72-h. The stainless steel rods of
the grid (3mm wide) were set 2-cm apart from each other. Food
and water were provided ad libitum. As soon as the animal tried
to sleep, it lost its muscle tone and thereby grip over the grid,
which made it fall in water and thus awakened the animal.
Drugs and Treatment Schedule
Animals were divided into different groups consisting of 10–
12 animals in each group based on their treatment paradigms.
Table 1 demonstrates the various treatment groups of the study.
American ginseng (Panax quinquefolius, family: Arileacea)
(Sigma-Aldrich, St. Louis, MO, USA) was suspended in 0.5%
(w/v) sodium carboxy-methyl cellulose (CMC) solution and
administered per oral in a constant volume of 1ml per 100
g of bodyweight. GABA modulators (picrtoxin, flumazenil)
were dissolved in 0.1% dimethylsulfoxide, while muscimol
was dissolved in distilled water. The GABA modulators were
administered as pre-treatments (30 min before P. quinquefolius
administration). Each group received treatment for a total period
of 8 days, starting 5 days prior to 72-h SD. Data of per se
groups for all the treatments (where the drug would have
been given to naïve animals to see their innate effects in non-
challenged animals) was not shown due to ethical constraints and
to minimize the use of experimental animals. The entire study
protocol design has been depicted in Figure 1.
Analysis of Ginsenosides in Panax
quinquefolius
A gradient HPLC method was employed for the qualitative
analysis of ginsenosides in the P. quinquefolius (American
ginseng). The American ginseng extract as well as standards
for ginsenosides (the standard ginsenosides Rb1, Rg1, Rc, Rb2,
and Rd Sigma-Aldrich, USA) were dissolved in HPLC grade
methanol (90:10). The HPLC system used was a Waters 2695
separation module (Waters, Milford, MA, USA) equipped with
a pump, auto-injector and Waters PDA detector, all controlled
by Empower software. The stationary phase used was a Thermo
Fischer Symmetry C18 column (5 µm, 4.6 mm ID × 250 mm,
Thermo Fischer, USA) thermostated at 25◦C, the corresponding
wavelength selected was 200 nm. The mobile phases consisted
of (A) acetonitrile (Sigma-Aldrich, USA) and (B) HPLC grade
water (Merck, USA) which were run across a gradient (gradient
specifications as mentioned in Table 2) at a flow rate of 0.80
mL/min. Figure 2 shows qualitative chromatogram of different
ginsenosides present in Panax quinquefolius.
Behavioral Assessments
Measurement of Locomotor Activity
The locomotor activity was recorded by using an actophotometer
(IMCORP, Ambala, India). The instrument consisted of a closed
arena equipped with 12 infrared light-sensitive photocells in two
rows (six in each row), at a distance of 3 and 9 cm respectively.
Before locomotor task, each animal was placed in the activity
chamber for 3 min for habituation and exploration. The actual
locomotor activity was then recorded for a period of 5 min.
The photo beams in actophotometer, interrupted by the animal’s
motion were taken as the measure of movements (ambulation
and rearing). Total activity (ambulation + rearing counts) was
recorded and expressed in terms of total photo beam counts cut
for 5 min per animal (Kalonia and Kumar, 2007).
Assessment of Anxiety like Behavior Using Mirrored
Chamber Test (MCT)
The mirror chamber was a structured wooden chamber (40 ×
40 × 30.5 cm) with a mirror cube of slightly lesser dimensions,
kept inside the wooden chamber. At the beginning of the test,
each animal was placed at the distal corner of themirror chamber.
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TABLE 1 | Treatment groups.
S. NO. Treatment Group (mg/kg) Treatment
1. Naïve Animals not subjected sleep deprivation, vehicle treated
2. Control (SD-72 h) 72-h sleep deprived; vehicle treated
3. GIN (50) P. quinquefolium (50 mg/kg) administered for 8 days, started 5 days before 72-h sleep deprivation
4. GIN (100) P. quinquefolium (100 mg/kg) administered for 8 days, started 5 days before 72-h sleep deprivation
5. GIN (200) P. quinquefolium (200 mg/kg) administered for 8 days, started 5 days before 72-h sleep deprivation
6. PTX (0.5) Picrotoxin (0.5 mg/kg) administered for 8 days started 5 days before 72-h sleep deprivation
7. PTX (0.5) + GIN (100) Picrotoxin (0.5 mg/kg) pretreatment followed by P. quinquefolium (American Ginseng 100 mg/kg)
administered for 8 days, started 5 days before 72 h sleep deprivation
8. FLU (0.5) Flumazenil (0.5 mg/kg) administered for 8 days started 5 days before 72-h sleep deprivation
9. FLU (0.5) + GIN (100) Flumazenil (0.5 mg/kg) pretreatment followed by P. quinquefolium (American Ginseng 100 mg/kg)
administered for 8 days, started 5 days before 72 h sleep deprivation
10. MUS (0.05) Muscimol (0.05 mg/kg) administered for 8 days started 5 days before 72-h sleep deprivation
11. MUS (0.05) + GIN (100) Muscimol (0.05 mg/kg) pretreatment followed by P. quinquefolium (American ginseng 100 mg/kg)
administered for 8 days, started 5 days before 72 h sleep deprivation
SD-72, Sleep deprivation of 72-h; GIN, Panax quinquefolius (American ginseng); PTX, Picrotoxin; FLU, Flumazenil; MUS, Muscimol.
FIGURE 1 | Figure describes the experimental design adopted during the 8 day protocol. GIN: Panax quinquefolius (American ginseng), SD, Sleep
Deprivation of 72-h; Veh, vehicle treatment.
After habituation and exploration period of initial 3 min, the test
session was recorded. During the 5 min test session, the following
parameters were noted (a) Latency to enter themirror cube inside
the wooden chamber, (b) Number of entries into the mirror cube
(c) Total time spent in the mirror cube. An anxiogenic response
was defined by increased latency to enter mirror cube, as well as
decreased number of entries and reduced time spent in themirror
cube (Kalonia and Kumar, 2007).
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FIGURE 2 | HPLC fingerprint of Panax quinquefolius (American ginseng).
TABLE 2 | Gadient conditions for HPLC.
Time (mins) Mobile phase (A) (%) Mobile phase (B) (%)
0 20 80
15 20 80
18 22 78
30 46 54
40 55 45
45 100 0
50 20 80
Biochemical Tests
Dissection and Homogenization
Thereupon, after the last behavioral test, animals were
randomized into distinct sets; the first set was used for the
biochemical assays (n = 5/group). For biochemical analysis,
animals were sacrificed by decapitation. Whole brain from
each animal was put over ice and weighed. 10% (w/v) tissue
homogenates were prepared in 0.1 M phosphate buffer (pH 7.4).
Following which the homogenates were centrifuged at 10,000 ×
g for 15 min and aliquots of supernatants were separated and
used for biochemical estimations.
Lipid Peroxidation Assay
The quantitative measurement of lipid peroxidation in the whole
brain was measured according to the method of Wills (1966).
The amount of malondialdehyde (MDA) concentration formed
was measured by the reaction with thiobarbituric acid at 532
nm using Perkin Elmer lambda 20 UV-vis spectrophotometer
(Norwalk, CT, USA). The results were expressed as nano moles
of MDA per milligram protein using the molar extinction
coefficient of chromophore (1.56×10 M/cm) and represented as
percentage of naive.
Estimation of Reduced Glutathione
Reduced glutathione (GSH) was estimated according to the
method described by Ellman (1959). 1.0 mL of homogenate
was precipitated using 1.0mL of 4% sulfosalicylic acid by
keeping the mixture at 4◦C for 1 h and the samples were
immediately centrifuged at 1200 g for 15 min at 4◦C. The assay
mixture contained 0.1mL of supernatant, 2.7mL of phosphate
buffer (pH 8.0) and 0.2 mL of 0.01 M-dithiobisnitrobenzoic
acid. The yellow color developed was read immediately at 412
nm using spectrophotometer (Perkin Elmer lambda 20 UV-
Vis spectrophotometer (Norwalk, CT, USA). The results were
expressed as nano moles of GSH per milligram of protein and
represented as percentage of naive.
Estimation of Nitrite Levels
The accumulation of nitrite in the supernatant (an indicator
of the production of nitric oxide (NO load), was determined
with a colorimetric assay using Greiss reagent (0.1% N- (1-
napthyl) ethylene diaminedihydrochloride, 1% sulfanilamide
and 2.5% phosphoric acid) as per the method reported by
Green et al. (1982). Equal volumes of supernatant and Greiss
reagent were mixed, incubated for 10 min at room temperature
and the absorbance of reaction mixture was read at 540 nm
using a spectrophotometer (Perkin Elmer lambda 20 UV-Visible
spectrophotometer, Norwalk, CT, USA). The concentration of
nitrite in the supernatant was determined from a standard
curve. The results were expressed as mg/ml and represented as
percentage of naïve.
Estimation of Catalase
Catalase activity was assayed by the method reported by Luck
(1965), wherein the breakdown of hydrogen peroxide (H2O2)
was measured at 240 nm. Briefly, the assay mixture consisted
of 3 mL of H2O2 phosphate buffer (1.25 × 10
−2M H2O2)
and 0.05 mL of supernatant of tissue homogenate (10%). The
change in absorbance was recorded at 240 nm using UV-Vis
spectrophotometer (Perkin Elmer lambda 20 spectrophotometer
(Norwalk, CT, USA). The results were expressed as micromole
H2O2 decomposed permilligram of protein/min and represented
as percentage of naive.
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Superoxide Dismutase Activity
Superoxide dismutase (SOD) activity was assayed by the method
of Kono (1978). According to the method, reduction of nitro blue
tetrazolium (NBT) was inhibited by the SOD and the change
in absorbance was recorded for 2 min at 30 s intervals by
measuring absorbance at 560 nm using Perkin Elmer Lambda
20 spectrophotometer. The results were expressed as units/mg
protein and represented as percentage of naive.
Protein Estimation
The protein content was measured according to Biuret method
described by Lowry et al. (1951) using bovine serum albumin as
the standard.
Mitochondrial Enzyme Complex Estimations
The brain samples of second set of animals were used for
evaluation of mitochondrial enzyme complex activities as
described by Berman and Hastings (1999). The whole brain was
homogenized in isolation buffer (215 mM mannitol, 75 mM
sucrose, 0.1% BSA, 20 mM HEPES, 1 mM EGTA, and pH 7.2).
Homogenates were centrifuged at 13,000 g for 5 min at 4◦C.
Pellets were re-suspended in isolation buffer with ethylene glycol
tetra acetic acid (EGTA) and spun again at 13,000 g at 4◦C for
5 min. The resulting supernatants were transferred to new tubes
and topped off with isolation buffer with EGTA and again spun at
13,000 g at 4◦C for 10 min. Pellets containing pure mitochondria
were re-suspended in isolation buffer without EGTA.
Nicotinamide Adenine Dinucleotide (NADH)
Dehydrogenase Activity
Complex-I was measured spectrophotometrically by the method
mentioned by King and Howard (1967). The method involved
catalytic oxidation of NADH to NAD+ with subsequent
reduction in cytochrome c. The reaction mixture contained
0.2M glycyl glycine buffer pH 8.5, 6mM NADH in 2mM glycyl
glycine buffer and 10.5mM cytochrome c. The reaction had
been initiated by addition of requisite amount of solubilised
mitochondrial sample to reaction mixture, followed by record
of absorbance change at 550 nm for 2 min and the results
were expressed nano moles of NADH oxidized per minute per
milligram protein and represented as percentage of naïve.
Succinate Dehydrogenase (SDH) Activity
Complex-II/SDH was measured spectrophotometrically
according to method reported by King (1967). The method
involved oxidation of succinate by an artificial electron acceptor,
potassium ferricyanide. The reaction mixture contained 0.2 M
phosphate buffer (pH 7.8), 1% BSA, 0.6 M succinic acid, and
0.03 M potassium ferricyanide. The reaction was initiated by
the addition of mitochondrial sample and absorbance change
was read at 420 nm for 2 min. The results were expressed as
nano moles of SDH per milligram of protein and represented as
percentage of naïve.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
(MTT) Assay
Also known as mitochondrial redox activity assay, this method
was based on the in vitro studies to evaluate the mitochondrial
redox activity via the conversion of MTT tetrazolium salt to
formazan crystals by mitochondrial respiratory chain reactions
in isolated mitochondria by the method of Liu et al. (1997). The
blue formazan crystals were solubilised with dimethylsulphoxide
and corresponding absorbance wasmeasured by an ELISA reader
at 580 nm filter. The results were expressed number of viable cells
per well and represented as percentage of naïve.
Cytochrome Oxidase Activity
Cytochrome oxidase activity was assayed in brain mitochondria
according to the method developed by Sottocasa et al. (1967).
The assay mixture contained 0.3mM reduced cytochrome C
in 75mM phosphate buffer. The reaction was started by the
addition of solubilized mitochondrial sample and the changes in
absorbance were recorded at 550 nm for 2 min (at intervals of 30
s each) and the results represented as percentage of naive.
Estimation of Serum Corticosterone [CORT]
Preparation of serum
Blood collected in the test tube was allowed to clot at room
temperature. The tubes were then centrifuged at 2000 rpm for
10 min, and the straw-colored serum was separated and stored
frozen at−20◦C.
Serum corticosterone was estimated as per the modified
method of Silber et al. (1958). The 0.2ml of serum was
treated with 0.2ml of freshly prepared chloroform/methanol
mixture (2:1 v/v), followed by 3ml of chloroform instead of
dichloromethane used in the procedure described by Siber and
his co-workers. The step of treatment of petroleum ether was
also omitted. The samples were vortexed for 30 s and centrifuged
at 2000 rpm for 10 min. The chloroform layer was carefully
removed with the help of a long 16-gauge needled syringe
and was transferred to a fresh tube. The chloroform extract
was then treated with 0.1 N NaOH by vortexing rapidly, and
corresponding NaOH layer was rapidly removed. The sample
was then treated with 3ml of 30 N H2SO4 and vortexed
vigorously. After phase separation, chloroform layer on top was
removed using a syringe as described above and discarded. The
tubes containing H2SO4 were kept in dark for 30–60 min and
thereafter fluorescence measurements carried out in fluorescence
spectrophotometer (F-2500 Hitachi, Japan) with excitation and
emission wavelength set at 472 and 523.2 nm, respectively. The
standard curve depicting the fluorescence yield vs. corticosterone
concentration was used for result analysis.
Estimation of TNF-α Activity
The brain of first set of animals was used for the estimation
of TNF- α levels in mice brain. The quantification of cytokine
TNF-α was performed as per the instructions specified in BD
Biosciences immunoassay kit (BD opt EIA by BD Bioscience, San
Jones, CA, USA) The mice TNF-α immunoassay was 4.5 h solid
phase ELISA which employed sandwich enzyme immune assay
technique. Monoclonal antibody specific for mice TNF-α had
been pre-coated in the microplate. When standards, control, and
samples were pipetted into the wells, any mice-TNF-α present
was bound by the immobilized antibody. After washing away
any unbound substance an enzyme linked polyclonal antibody
specific for mice TNF-α was added to the wells. Following a wash
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to remove any unbound antibody-enzyme reagent, a substrate
solution was added to the wells. The enzyme reaction yielded
a blue product that turned yellow when the stop solution was
added. The intensity of the color measured (using a microtiter
plate reader read at 450 nm) was found to be in proportion to
the amount of mice TNF-α bound in the initial steps. The sample
values were then read off the standard curve.
Histopathological Analysis by Hematoxylin
and Eosin Staining (H and E Staining)
Tissue Sections Preparation
Third set of animals were scarified immediately after last
behavioral test and perfused transcardially via the ascending
aorta with cold phosphate buffered saline (0.1 M, pH 7.4). The
whole brain was dissected out and fixed overnight at 4◦C in the
same buffer containing 10% (v/v) paraformaldehyde. The brain
was then washed with 0.1 M PBS (pH 7.4) for 1 h, dehydrated
in alcohol, and then embedded in paraffin wax. Serial coronal
sections (5–10 µm thickness) of whole brain were then obtained
using a freezing microtome.
Haematoxylin and Eosin (H&E) Staining
The brain sections (5–10 µm) thick were de-waxed and stained
with haematoxylin and eosin. Briefly, sections were immersed in
the filtered haematoxylin solution for 1 min followed by rinsing
with tap water. Then, the sections were immersed in eosin stain
for 1–2 min and rinsed thoroughly with tap water followed by
dehydration in ascending alcohol solutions (50, 70, 80, 95, 97, and
100% alcoholic solutions). Now the sections were mounted on
labeled slides. The stained sections were viewed under a binocular
microscope (Nikon Eclipse 80i, Nikon Instruments Inc., USA) at
40× targeting the thalamo-cortical regions of the brain for the
presence of morphological changes and thereby photographed.
The particular encephalic areas were analyzed for the presence
and density of pyknotic nuclei. The number of such pyknotic
nuclei per square pixel were analyzed using computer based
image analysis (Image J 1.42q, NIH, USA).
Statistical Analysis
All statistical procedures were carried out using sigma stat Graph
Pad Prism (Graph Pad prism Software, version 5, San Diego,
CA). All the values were expressed as mean ± SEM. The data
was analyzed using analysis of variance (ANOVA) followed by
Post-hoc evaluation utilizing the Tukey’s test. In all the tests, the
criterion for statistical significance was p < 0.05.
RESULTS
Effects of Panax quinquefolius (GIN)
Treatment and Its Regulation by GABA
Modulators on Behavioral Test Paradigms
(Locomotor Activity and Mirror Chamber
Test Performance) in 72-h Sleep Deprived
Animals
Seventy two hours of sleep deprivation significantly impaired
locomotor activity as well as precipitated anxiety like behavior
[as depicted by increased time latency to enter the mirror
cube, decreased number of entries as well as depleted duration
spent in mirror cube] as compared to the naive group (p <
0.05). Panax quinquefolius (GIN) treatment (100 and 200mg/kg)
for 8 days significantly improved locomotor activity as well
as exhibited antianxiety like effect as compared to the control
group (72-h SD) group (p < 0.05) (Tables 3, 4 respectively).
However, Panax quinquefolius (GIN) 50 mg/kg did not produce
any significant improvement in locomotor activity as well as
anxiety like behavior as compared to 72-h sleep deprived control
group. The effect of Panax quinquefolius (GIN) was further
found to be regulated by GABA modulators. Pre-treatment of
flumazenil (0.5 mg/kg) [GABA-BZD receptor antagonist] and or
picrotoxin (0.5mg/kg) [GABA chloride channel blocker] with
Panax quinquefolius (GIN) (100mg/kg) for 8 days, significantly
reversed the protective effect of Panax quinquefolius (GIN)
in 72-h sleep deprived animals (p < 0.05) as compared to
their individual effects. However, muscimol [GABAA selective
agonist] (0.05mg/kg) pretreatment with Panax quinquefolius
(GIN) (100mg/kg) for 8 days significantly potentiated their
protective effect which was significant as compared to their effects
per se (p < 0.05) (Tables 3, 4).
Effects of Panax quinquefolius (GIN)
Treatment and Its Modulation by GABA
Modulators on Sleep Deprivation Induced
Oxidative Stress
The results depicted in Table 5 signify that 72-h sleep deprivation
significantly caused oxidative stress like conditions as evidenced
by rise in lipid peroxidation, nitrite concentration, as well
as depletion of reduced GSH, superoxide dismustase (SOD)
and catalase activity as compared to the naive group (p <
0.05). Treatment with Panax quinquefolius (GIN) (100 and
200mg/kg) for 8 days significantly attenuated conditions of
TABLE 3 | Effect of Panax quinquefolius (GIN) and its interaction with
GABA modulators on locomotor activity in 72-h sleep deprived animals.
S. No. Treatment group (mg/kg) Total activity day 8 (Counts/5 min)
1 Naïve 204.00±2.75
2 Control (SD-72 h) 63.428±5.68a
3 GIN (50) 71.66±6.36a
4 GIN (100) 119.875±8.87b,c
5 GIN (200) 135.67±5.62b,c
6 PTX (0.5) 64.42±5.50a
7 PTX (0.5) + GIN (100) 78.0±2.65a,d
8 FLU (0.5) 66.21±3.41a
9 FLU (0.5) + GIN (100) 81.33±4.11a,d
10 MUS (0.05) 70.60±4.61a
11 MUS (0.05) + GIN (100) 195.21±3.97b,d,e
Values are expressed as mean ± SEM. ap < 0.05 as compared with naive, bp < 0.05 as
compared with control (SD-72),cp < 0.05 as compared with GIN (50 mg/kg), dp < 0.05
as compared with GIN (100 mg/kg), ep < 0.05 as compared with MUS (0.05 mg/kg).
(One-way ANOVA followed by Tukey’s test). SD-72, Sleep deprivation of 72-h; GIN, Panax
quinquefolius (American ginseng); PTX, Picrotoxin; FLU, Flumazenil; MUS, Muscimol.
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TABLE 4 | Effect of Panax quinquefolius (GIN) on anxiety like behavior as represented by the Mirror Chamber Test performance and its interaction with
GABA modulators in 72-h sleep deprived animals.
S. No Treatment Groups (mg/kg) Latency to enter mirror cube (seconds) Number of entries in mirror cube Time spent in mirror cube (seconds)
1 Naïve 55.41± 7.54 8.42±1.23 89.13±6.25
2 Control (SD-72 h) 174.40± 9.66a 1.27±0.61a 24.08±0.75a
3 GIN (50) 160.27± 8.91a 2.35±0.42a 32.13±4.43a
4 GIN (100) 99.56± 4.02b,c 5.62±0.3b,c 53.34±4.77b,c
5 GIN (200) 73.14± 6.04b,c 6.01±0.4b,c 67.42±5.14b,c
6 PTX (0.5) 176.62± 7.13a 1.39±0.44a 26.14±1.92a
7 PTX (0.5) + GIN (100) 161.26± 5.61a,d 1.97±0.47a,d 31.43±3.12a,d
8 FLU (0.5) 178.45± 5.01a 1.51±0.44a 27.43±2.12a
9 FLU (0.5) + GIN (100) 157.51± 6.64a,d 2.22±0.88a,d 34.17±3.22a,d
10 MUS (0.05) 165.23± 3.11a 2.01±0.81a 30.71±1.46a
11 MUS (0.05) + GIN (100) 67.43± 1.79b,d,e 9.62±1.1b,d,e 82.34±4.04b,d,e
Values are expressed as mean ± SEM. ap < 0.05 as compared with naive, bp < 0.05 as compared with control (SD-72), cp < 0.05 as compared with GIN (50 mg/kg), dp < 0.05
as compared with GIN (100 mg/kg), ep < 0.05 as compared with MUS (0.05 mg/kg). (One-way ANOVA followed by Tukey’s test). SD-72, Sleep deprivation of 72-h; GIN, Panax
quinquefolius (American ginseng); PTX, Picrotoxin; FLU, Flumazenil; MUS, Muscimol.
oxidative stress [alleviated MDA, nitrite concentration and
restored SOD, catalase activities as well as GSH levels] as
compared to control group (p < 0.05). Further, pretreatment
with Muscimol (0.05mg/kg) for 8 days) significantly potentiated
antioxidant like profile of Panax quinquefolius (GIN) (100mg/kg
which was significant as compared to their effects alone in
sleep deprived control animals (p < 0.05). However, picrotoxin
(0.05mg/kg) and flumazenil (0.5mg/kg) pretreatment with
Panax quinquefolius (GIN) (100mg/kg) for 8 days significantly
reversed the protective effect of Panax quinquefolius (GIN) in
72-h sleep deprived animals (p < 0.05) (Table 5) which was
also significant as compared to their individual effects in sleep
deprived animals.
Effects of Panax quinquefolius (GIN) and
Its Combination with GABA Modulators on
Sleep-Deprivation Induced Impairment of
Mitochondrial Respiratory Enzyme
Complex Activities
Mitochondrial enzyme complex activities (NADH
dehydrogenase, succinate dehydrogenase and cytochrome
oxidase activities as well as cell viabilities) were significantly
depleted in 72-h sleep deprived animals as compared to naive
group (p< 0.05) (Figure 3). Treatment with Panax quinquefolius
(GIN) (100 and 200mg/kg) significantly restored the activities
of mitochondrial enzyme complexes I, II, IV and increased
cell viability as compared to control (72-h SD) group (p <
0.05). However, Panax quinquefolius (GIN) (50mg/kg) did
not produce any significant restorative effect on depleted
mitochondrial enzyme complex activities as compared to the
72-h sleep deprived group. Furthermore, muscimol (0.05mg/kg)
pretreatment with Panax quinquefolius (GIN) (100mg/kg) for 8
days significantly potentiated their protective effect and restored
mitochondrial enzyme complex activities which was significant
as compared to their effects per se in sleep deprived animals
(p < 0.05). However, both picrotoxin (0.05mg/kg) and or
flumazenil (0.5mg/kg) pretreatment with Panax quinquefolius
(GIN) (100mg/kg) for 8 days significantly reversed its protective
effect against impaired mitochondrial enzyme complex activities
in 72-h sleep deprived animals (p < 0.05). This depicts that the
restorative potential of Panax quinquefolius (GIN) treatment
against sleep deprivation induced depleted mitochondrial
enzyme complex activities was inflected by GABA modulators.
Effect of Panax quinquefolius (GIN) and Its
Modification by GABA Modulators on
Sleep Deprivation Induced Elevated Serum
Corticosterone (CORT) levels
Sleep deprived (72-h) animals showed a significant increase
in serum CORT levels as compared with naïve group (p <
0.05). Treatment with Panax quinquefolius (GIN) (100, 200
mg/kg) significantly (p < 0.05) attenuated serum CORT levels as
compared with control group (72-h SD) (Figure 4). Treatment
with Panax quinquefolius (GIN) (50mg/kg) did not produce
any significant restorative effect on serum CORT levels as
compared to the 72-h sleep deprived group. The protective
effect of Panax quinquefolius (GIN) treatment against elevated
serum CORT levels was found to be regulated by GABA
modulators pretreatment. 8 days picrotoxin (0.05mg/kg) and or
flumazenil (0.5mg/kg) pretreatment with Panax quinquefolius
(GIN) (100mg/kg) significantly reversed this protective effect
of Panax quinquefolius (GIN) (p < 0.05). Furthermore, in 72-
h SD animals pretreatmemnt of muscimol (0.05mg/kg) with
Panax quinquefolius (GIN) (100mg/kg) significantly (p < 0.05)
potentiated their protective effect (depleted serum CORT level),
as compared with their individual effects alone.
Effect of Panax quinquefolius (GIN) and its
Modification by GABA Modulators on
TNF-α in Sleep-Deprived Mice
As depicted in Figure 5, 72-h sleep deprivation significantly
increased encephalic TNF-α levels as compared to naïve group
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FIGURE 3 | Effects of Panax quinquefolius (GIN) and its combination with GABA modulators on sleep-deprivation induced impairment of
mitochondrial respiratory enzyme complex activities. Complex-I (NADH dehydrogenase activity); Complex-II (Succinate dehydrogenase activity); Complex-III
(MTT/ mitochondrial redox activity); Complex IV (cytochrome c oxidase activity). Values are expressed as mean ± SEM and expressed as percentage of naive. ap <
0.05 as compared with naive, bp < 0.05 as compared with control (SD-72), cp < 0.05 as compared with GIN (50 mg/kg), dp < 0.05 as compared with GIN
(100mg/kg), ep < 0.05 as compared with MUS (0.05mg/kg). (One-way ANOVA followed by Tukey’s test). SD-72, Sleep deprivation of 72-h; GIN:,Panax quinquefolius
(American ginseng); PTX, Picrotoxin; FLU, Flumazenil; MUS, Muscimolss.
FIGURE 4 | Effect of Panax quinquefolius (GIN) and its modification by GABA modulators on sleep deprivation induced elevated serum corticosterone
(CORT) levels. Values are expressed as mean ± SEM. ap < 0.05 as compared with naive, bp < 0.05 as compared with control (SD-72), cp < 0.05 as compared with
GIN (50 mg/kg), dp < 0.05 as compared with GIN (100mg/kg), ep < 0.05 as compared with MUS (0.05mg/kg). (One-way ANOVA followed by Tukey’s test). SD-72,
Sleep deprivation of 72-h; GIN, Panax quinquefolius (American ginseng); PTX, Picrotoxin; FLU, Flumazenil; MUS, Muscimol.
(p < 0.05). Unlike with lower dose (50mg/kg), treatment
with Panax quinquefolius (GIN) (100, 200mg/kg) for 8 days
significantly attenuated TNF α levels as compared to control
group (p < 0.05). Furthermore, picrotoxin (0.5mg/kg) and
flumazenil (0.5mg/kg) pretreatment with Panax quinquefolius
(GIN) (100mg/kg) significantly reversed this protective effect of
Panax quinquefolius (GIN) (raised TNF-α level) in 72-h sleep
deprived animals (p < 0.05). However, muscimol (0.05mg/kg)
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pre-treatment with Panax quinquefolius (GIN) (100mg/kg)
potentiated their protective effect (attenuated TNF-α levels)
which was significant as compared to their effect alone in 72-h
sleep deprived animals (p < 0.05).
Effect of Panax quinquefolius (GIN) and its
Modification by GABA Modulators on
Neuronal Morphology as Depicted by
Histopathological Sections of Sleep
Deprived Mice Brains
Histopathological evaluation of thalamo-cortical region of brains
of sleep deprived mice was conducted by light microscopy.
Representative images of brain sections from different animal
groups are shown in Figure 6I. In the histopathological
evaluation, brains of naïve animals showed comparatively
undamaged and optimum sized neuronal cells and cell layers as
compared to control, i.e., 72-h sleep deprived animals. However,
disorganization of various cell layers, increase in density of
pyknotic cells (signifying neuroinflammatory changes), was
observed in thalamo-cortical regions of the brains of sleep
deprived animals. Treatment with Panax quinquefolius (GIN)
(100 and 200mg/kg) attenuated these neuroinflammatory
changes in neuronal morphologies in sleep deprived animals
as compared to the control group (Figure 6I). In addition,
the number of pyknotic cells, per 128,800 square pixels of
area were found to be higher in the thalamo-cortical regions
of 72-h sleep deprived animals (control group), as compared
to the naïve group (p < 0.05). 8 days treatment with Panax
quinquefolius (GIN) 100 and 200mg/kg significantly brought
about a reduction in number of pyknotic cells as compared
to the control group (p < 0.05). Furthermore, this protective
effect of Panax quinquefolius (GIN) treatment against increased
pyknotic cell density was significantly regulated by GABA
modulators pretreatments. While, picrotoxin (0.5 mg/kg) and or
flumazenil (0.5mg/kg) pretreatment with Panax quinquefolius
(GIN) (100mg/kg) significantly reversed the protective effect of
Panax quinquefolius (GIN). Further, pretreatment withmuscimol
(0.05 mg/kg) significantly potentiated its (GIN) protective effect
against (decreased pyknotic cell density), which was significant as
compared to their effect per se (p < 0.05) (Figures 6II, 7).
DISCUSSION
The findings of the present study encompass the behavioral,
biochemical as well as neuroinflammatory alterations
accumulated as a result of 72-h of SD as well as the
neuroprotective effect and underlying mechanisms of Panax
quinquefolius against the above mentioned manifestations.
Sleep is an important homeostatic phenomenon and SD
has been often linked to several neurological debilities for
ex. depression, anxiety like behavior, cognitive dysfunction,
hyperalgesic conditions etc. Several mechanisms have been
suggested to explain the complex aetiological cascade responsible
for development of SD induced neurological comorbidities
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FIGURE 5 | Effect of Panax quinquefolius (GIN) and its modification by GABA modulators on TNF-α in sleep-deprived mice. Values are expressed as
mean ± SEM. ap < 0.05 as compared with naive, bp < 0.05 as compared with control (SD-72), cp < 0.05 as compared with GIN (50mg/kg), dp < 0.05 as compared
with GIN (100 mg/kg), ep < 0.05 as compared with MUS (0.05 mg/kg). (One-way ANOVA followed by Tukey’s test). SD-72, Sleep deprivation of 72-h; GIN, Panax
quinquefolius (American ginseng); PTX, Picrotoxin; FLU, Flumazenil; MUS, Muscimol.
FIGURE 6 | (I) Effects of Panax quinquefolius (GIN) alone and in combination with GABA modulators on neuronal morphology as depicted by photomicrographs of
histopathological sections (at 40X) of sleep deprived mice brains. (A) Naïve; (B) Sleep deprived (72 h); (C) GIN (50); (D) GIN (100); (E) GIN (200); (F) PTX (0.5); (G) PTX
(0.5) + GIN (100); (H) FLU (0.5); (I) FLU (0.5) + GIN (100); (J) MUS (0.05); (K) MUS (0.05) + GIN (100). :Pyknotic cells depicting mild inflammation of neurons
(II) The histopathological sections as modified by software for processing; showing outliners of pyknotic cells; (A) Naïve; (B) Sleep deprived (72 h); (C) GIN (50); (D)
GIN (100); (E) GIN (200); (F) PTX (0.5); (G) PTX (0.5) + GIN (100); (H) FLU (0.5); (I) FLU (0.5) + GIN (100); (J) MUS (0.05); (K) MUS (0.05) + GIN (100).
particularly oxidative stress, mitochondrial dysfunction, HPA-
axis activation, neuroinflammation as well as apoptosis (Kumar
and Chanana, 2014).
In our study, subjection of animals to 72-h of SD brought
about intense behavioral alterations like motor dysfunction
and anxiety like behavior as evidenced by decreased locomotor
activity as well as increased latency and decreased number
of entries as well as duration in the mirror cube in mirror
chamber test paradigm, as compared to the naïve group.
Additionally, biochemical correlates in the present study signify
the accumulation of oxidative free radicals (characterized
by increased lipid peroxidation, nitric oxide load and
depleted reduced glutathione, catalase and SOD activities)
and depleted activity of mitochondrial enzyme complexes
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FIGURE 7 | Graph representing the effect of Panax quinquefolius (GIN) and modulatory effect of GABA modulators on ginseng’s activity on pyknotic
cell expression per 1228800 square pixel; Values are expressed as mean ± SEM and expressed as percentage increase of naive. ap < 0.05 as compared
with naive, bp < 0.05 as compared with control (SD-72), cp < 0.05 as compared with GIN (50mg/kg), dp < 0.05 as compared with GIN (100mg/kg), ep < 0.05 as
compared with MUS (0.05mg/kg). (One-way ANOVA followed by Tukey’s test). SD-72, Sleep deprivation of 72-h; GIN, Panax quinquefolius (American ginseng); PTX,
Picrotoxin; FLU, Flumazenil; MUS, Muscimol.
(NADH dehydrogenase, succinate dehydrogenase activity,
cytochrome C oxidase and impaired the neural cell viability) as
a direct consequence of 72-h of SD. Distinct lines of evidence
suggest that SD on chronic basis may lead to differential
alterations in the GABA mediated inhibitory signaling and may
also precipitate dynamic changes in the density of GABAA
receptors [GABAAR] in various areas of the brain responsible
for regulation of sleep/ wake flip flop cycle (Watt et al., 2000;
Tononi and Cirelli, 2006). It can be purported that conditions
of oxidative stress that may be precipitated via interplay
between NOX2 activation and mitochondrial enzyme complex
impairment (as a consequence of SD) may prove detrimental to
GABA-ergic neurons as well as inhibitory signaling. Studies have
demonstrated a direct link between NOX2 upregulation and
depleted GABA ergic inhibitory signaling. It has been evident
that a paracrine effect of increased NOX2 activity is that it causes
dysfunction of the fast spiking, parvalbumin (PV)-expressing
subpopulation of inhibitory GABAergic interneurons, thereby
blocking the inhibitory effect (Behrens et al., 2007; Dugan et al.,
2009). Further, this effect of NOX2 has been reported to be
regulated via proinflammatory cytokines like IL-6 (Behrens
et al., 2008) levels. Thus, with the above backdrop it can be
concluded that GABA-ergic downregulation may serve as pivotal
aetiological links in development of secondary neurological
disorders associated with SD like motor dysfunctions, anxiety
like behavior etc. (Kumar and Singh, 2009).
SD has been documented to aid microglial activation and
thus lead to elevated levels of pro inflammatory markers such
as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and
C-reactive protein (CRP) (Hu et al., 2003; Meier-Ewert et al.,
2004). In consistence with the above reports, the current study
too demonstrated a significant increase in the encephalic levels
of TNF-α in sleep deprived animals as compared to the naive
animals, indicating the role of neuroinflammation in SD induced
pathophysiologies. This may signify a situation of microglial
activation as a consequence of SD. Recently, TNF-α levels
have also shown to regulate GABA ergic inhibitory synapse
function. The activation of TNF-α receptor 1 (TNFR1), may
lead to attenuation of inhibitory synaptic strength as well as
endocytosis of membranal GABAARs (Stellwagen et al., 2005;
Pribiag and Stellwagen, 2013). Thus, through the present study
it can be purported that one of the mechanisms behind SD
mediated alterations in GABA-ergic signaling and consequent
development of secondary neurological debilities could be
mediated via TNFR1 activation.
Being a kind of stress, exposure to sleep deprivation may
induce activation of the hypothalamo-pituitary-adrenal (HPA)
axis (Shansky and Lipps, 2013). This HPA axis activation
provokes corticosterone secretion which further triggers the
release of oxidative stress markers causing impairment of
various neurological functions. In concordance with the above
mentioned reports, the present study too demonstrated that
exposure of animals to SD of 72-h led to HPA-axis activation
demonstrated by considerably raised serum corticosterone levels
in comparison to the naïve animals. Supplementary to this the
increased corticosterone levels have been documented to alter
GABA ergic signaling. This is induced via alterations in receptor
configurations, decrease in GABA release from presynaptic
neurons as well as change in the levels of GAD 65 (glutamate
decarboxylase employed in the synthesis of GABA) (Verkuyl
et al., 2005; Lussier et al., 2013). This may suggest another
plausible mechanism for SD induced damage to the GABA-ergic
signaling and consequent precipitation of anxiety like behavior.
The current study targeted the thalamo-cortical regions of
the brain for studying the histopathological correlates in brains
of SD animals because synchronization and desynchronization
of thalamo-cortical circuits have been found to play an
important role in the electrophysiological transitory events
between sleep and wakefulness (Steriade, 1996; Pace-Schott and
Hobson, 2002). Histopathological evaluations in the present
study demonstrated neuroinflammatory responses and apoptotic
conditions in discrete brain areas of sleep deprived animals as
manifested by significantly higher density of pyknotic neuronal
cells when compared to naïve animals. This may be responsible
for disruptive functioning of the thalamo-cortical circuitry as
well as disruption of sleep wake homeostasis which may further
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FIGURE 8 | Posssible GABA-ergic involvement in the development of SD induced anxiety like behavior and targets in the neuroprotective effect of
Panax quinquefolius (American ginseng). ROS, reactive oxidative species; OS, oxidative stress; GAD65, glutamate decarboxylase; MAPK, Mitogen activated
protein kinase; PPI, protein phosphatase I; TNFR1, TNF-α receptor 1. The figure clearly depicts the various mechanisms involved in disruptive GABA-ergic inhibitory
signaling precipitated by sleep deprivation which may lead to development of anxiety like behavior. The elevated TNF-α levels affect GABA-ergic signaling by
decreasing the release of GABA vesicles presynaptically as well as by causing endocytosis of post-synaptic GABAA receptors, mediated by its binding to TNFR1. The
activation of TNFR1 dephosphorylates GABAA receptors via PPIvia mediation of p38 and MAPK pathways and thus causes endocytosis of GABAA. Also the elevated
corticosterone levels lead to decreased activity of GAD65 the main enzyme involved in the synthesis of GABA from glutamate, in the presynaptic cell. All these events
contribute to disruptive GABA-ergic inhibitory signaling.
serve as causative for development of anxiety like behavior in SD
animals.
Several studies have reported that the CNS benefits of Panax
quinquefolius (GIN) can be attributed to the pharmacological
activities of its active constituents, the triterpenoid saponins
called ginsenosides. These ginsenosides influence neurological
functions in terms of its anti-inflammatory, antioxidant, and
antiapoptotic like properties (Leung and Wong, 2010; Radad
et al., 2011). In concordance with the above mentioned
research inferences, the present study too reported that
Panax quinquefolius (GIN) treatment for 8 days in sleep
deprived animals significantly attenuated the anxiogenic like
behavior, oxidative stress, mitochondrial dysfunction, serum
corticosterone and pro-inflammatory marker (TNF-α) levels as
well as minimized histological neuronal changes as compared
to the sleep deprived vehicle treated animals. Although GABA
is known to be a primarily involved in consequences of SD,
but sleep research in recent times has also pointed toward
significant alterations in 5-HT neurotransmission as well as
neurochemical metabolism (under the control of molecules like
5-hydroxytryptamine transporter, 5-HTT and Glycogen synthase
kinase 3-β) as a direct consequence of SD (Benedetti et al.,
1999, 2012; Monti et al., 2011; Zant et al., 2011; Elmenhorst
et al., 2012; Sharma et al., 2015). Also, 5-HT receptor antagonists
have recently be classified for their promising role against SD-
induced brain dysfunctions (Youngblood et al., 1999; Morairty
et al., 2008) affirming that the secondary neurological debilities
manifested as a direct concern of SD can also be accredited
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to altered 5-HT neurotransmission. Also the active constituents
of Panax quinquefolius (ginsenosides, other phytosterols as well
as total saponins) have shown to be substantially involved in
modulation of 5-HT neurotransmission as well expression and
modulation of receptor activity. It has been demonstrated that
protective effect of Panax quinquefolius against neuropsychiatric
disorders was manifested through its specific effects on serotonin
levels in specific brain areas (Beveridge et al., 2002; Chatterjee
et al., 2012). Furthermore, ginsenoside Rg and ginsenoside
metabolites such as compound K and M4 have reported to cause
inhibition of 5-HT3 receptor-gated ion currents in Xenopus
oocytes expressing 5-HT3A receptors (Choi S. et al., 2003;
Lee et al., 2004). Lee et al mechanistically depicted the effect
of ginsenosides on 5-HT receptors via the interaction with
residues F292, V291, and I295 in the channel gating region of
transmembrane domain 2 (TM2) of the receptor (Lee et al.,
2004). Therein following the above background the potential
neuroprotective effect of Panax quinquefolius against SD induced
anxiety like behavior can also be attributed to alteration of 5-HT
neurotransmission.
Furthermore, it was hypothesized that neuroproprotective
potential of Panax quinquefolius’s (GIN) in SD induced anxiety
like behavior could be manifested by its GABA modulating
actions. Therefore, our study undertook an extended effort to
see interaction of Panax quinquefolius (GIN) with GABA-ergic
modulators. In the present study, picrotoxin and flumazenil
(GABA Cl− channel inhibitor as well as GABA-benzodiazepine
receptor inhibitor respectively) pre-treatment with Panax
quinquefolius (GIN) for 8 days significantly reversed the
protective effect (depleted gross motor activity, increased anxiety
like behavior, oxidative stress, mitochondrial dysfunction,
elevated corticosterone and TNF-α levels) of Panax quinquefolius
(GIN) with respect to its action alone in animals subjected to SD.
However, muscimol (GABA A selective agonist) pre-treatment
with Panax quinquefolius (GIN) significantly potentiated its
neuroprotective effect suggesting the involvement of GABA-
ergic modulating mechanisms underlying the neuroprotective
effect of Panax quinquefolius (GIN) against SD induced anxiety
like behavior, oxidative stress and neuroinflammation. The
GABA ergic modulatory potential of Panax quinquefolius as
purported by the present study is line with earlier mentioned
reports where Panax quinquefolius (GIN) has shown to
affect the neurotransmission of acetyl choline and GABA by
mechanisms involving the regulation of the expression of the
synthetic enzyme, regulation of the ligand binding capacities,
neurotransmitter release as well as signaling pathways involved
in the particular neurotransmitter system (Yuan et al., 1998; Kim
et al., 2001; Choi S. et al., 2003; Lee et al., 2013).
But still the results of the present study would require robust
cellular confirmations giving a proposition that further research
in this area may be required. Figure 8 tries to explain the findings
of the present study and the plausible targets of action of Panax
quinquefolius (GIN) against SD induced anxiety like behavior.
CONCLUSION
The present study recommended the possible involvement
of GABA-ergic mechanism in the protective effect of Panax
quinquefolius (GIN) against 72-h sleep deprivation induced
anxiety like behavior, oxidative stress, mitochondrial dysfunction
and neuroinflammation. Further, study provides a hope that
Panax quinquefolius (GIN) could be used as an adjuvant therapy
in the management of SD induced anxiety like behavior.
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